abstract |
The present invention relates to an insulin analog having a reduced insulin titer and a reduced insulin receptor binding affinity compared to the natural form in order to increase the half-life of insulin in blood, a conjugate prepares by linking the insulin analog and a carrier, a long-acting formulation including the conjugate, and a procedure for preparing the conjugate. |